TY  - BOOK
AU  - Cary, Brittany
TI  - NIH funding of COVID-19 research in 2020: a cross-sectional study
SN  - 2044-6055
PY  - 2022///
KW  - *Biomedical Research
KW  - *COVID-19
KW  - COVID-19/ep [Epidemiology]
KW  - Cross-Sectional Studies
KW  - Financing, Organized
KW  - Humans
KW  - National Institutes of Health (U.S.)
KW  - United States
KW  - MedStar Washington Hospital Center
KW  - Nursing
KW  - Journal Article
KW  - Research Support, Non-U.S. Gov't
N2  - CONCLUSION: In the first year of the pandemic, the NIH diverted a small fraction of its budget to COVID-19 research. Future health emergencies will require research funding to pivot in a timely fashion and funding levels to be proportional to the anticipated burden of disease in the population. Copyright © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ; DESIGN: Cross-sectional study; MAIN OUTCOMES AND MEASURES: The primary outcome was to determine the number of grants and funding amount the NIH allocated for COVID-19 by research type and clinical/scientific area. The secondary outcome was to calculate the time from the funding opportunity announcement to the award notice date; OBJECTIVE: This study aims to characterise and evaluate the National Institutes of Health's (NIH's) grant allocation speed and pattern of COVID-19 research; PARTICIPANTS: 1108 grants allocated to COVID-19 research; RESULTS: The NIH awarded a total of 56 169 grants in 2020, of which 2.0% (n=1108) wwas allocated for COVID-19 research. The NIH had a US; SETTING: COVID-19 NIH RePORTER Dataset was used to identify COVID-19 relevant grants
UR  - https://dx.doi.org/10.1136/bmjopen-2021-059041
ER  -